Clarithromycin + Rivaroxaban Interaction
Unknowninteraction on record
Description
Although clarithromycin is a combined P-gp and strong CYP3A inhibitor, pharmacokinetic data suggests that no precautions are necessary with concomitant administration with XARELTO as the change in exposure is unlikely to affect the bleeding risk [see Clinical Pharmacology (12.3) ] .
Source: FDA drug label - rivaroxaban